search query: @indexterm Decision analysis / total: 468
reference: 24 / 468
| Author: | Stonebraker, J. S. |
| Title: | How Bayer makes decisions to develop new drugs |
| Journal: | Interfaces
2002 : NOV-DEC, VOL. 32:6, p. 77-90 |
| Index terms: | Decision analysis Pharmaceutical industry |
| Freeterms: | Drugs industry |
| Language: | eng |
| Abstract: | Drug development is time consuming, resource intensive, risky, and heavily regulated. To ensure that it makes the best drug-development decisions, Bayer Pharmaceuticals uses a structured process based on the principles of decision analysis to evaluate the technical feasibility and market potential of its new drugs. DB had analyzed s few had analyzed a few business cases for review by Pharma. |
SCIMA